Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion type Assertion NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_head.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion description "[As with Japanese HCV patients with genotypes 1b/II-2b/IV, higher hepatic IFNAR mRNA expression in the United States with predominant genotypes 1a/I and 1b/II appears to correlate with response to IFN therapy and a low HCV RNA titer but not with the total HAI or its components.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_provenance.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion evidence source_evidence_literature NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_provenance.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion SIO_000772 10505743 NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_provenance.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion wasDerivedFrom befree-2016 NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_provenance.
- NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_assertion wasGeneratedBy ECO_0000203 NP264495.RALb6o5bNp6vdf0HXQkRBQLZOKD0KvRPYAh43eZW6BcFU130_provenance.